CD8A and neoplasm: Finally, the T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain (TIGIT), expressed on CD8+ and CD4+ T cells, as well as natural killer (NK) cells, interacts with its ligand CD155 on tumor cells, suppressing immune function and promoting immune evasions.